ProfileGDS5822 / ILMN_2985111
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 94% 96% 94% 94% 96% 95% 97% 95% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 186694
GSM1276600PDAC Late Ablation Control 21388.796
GSM1276601PDAC Late Ablation Control 31176.494
GSM1276602PDAC Late Ablation 1897.694
GSM1276603PDAC Late Ablation 21642.696
GSM1276604PDAC Late Ablation 31243.495
GSM1303940PDAC Late Ablation_anti-CTLA4 12049.797
GSM1303941PDAC Late Ablation_anti-CTLA4 21402.895
GSM1303942PDAC Late Ablation_anti-CTLA4 3156396